The first adult CAR T-cell treatment for lymphoma or leukemia has been approved by the FDA.

Published Date: 20 Mar 2024

The US. s. The FDA has authorized Breyanzi, a medication made by Bristol Myers Squibb that combines lipase and maraleucel (liso-cel), as the first CD19-directed chimeric antigen receptor (CAR) T-cell therapy for adult patients experiencing relapses.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Babies Are Bleeding to Death as Parents Reject a Vitamin Shot Given at Birth

2.

Detecting pancreatic cancer through changes in body composition and metabolism

3.

In heavily pretreated DLBCL, Triplet Scores a Survival Victory.

4.

The pandemic had little impact on mental health symptoms.

5.

Men over 75 years old may be significantly more likely to commit suicide if they have cancer.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot